Literature DB >> 16184427

Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils.

Kazushi Sakurai1, Toshihiro Osaka, Katsuya Yamasaki.   

Abstract

Mucosal inflammation is a crucial factor for the recurrence of peptic ulcer. In this study, we examined the effect of rebamipide on neutrophils infiltration, lipid peroxidation, and antioxidative enzyme activities in the recurrence of experimental gastric ulcer. Ulcer recurrence was examined at 60, 100, and 140 days after production of acetic acid-induced gastric ulcers in rats. Gastric neutrophil infiltration, lipid peroxidation, and antioxidative enzyme activities were determined by analyses of myeloperoxidase (MPO) activity, thiobarbituric acid reactive substance (TBARS) levels, and glutathione peroxidase (GSHpx) and superoxide dismutase (SOD) activities in the ulcer region, respectively. The effect of rebamipide, an antigastric-ulcer agent, on ulcer recurrence was assessed following oral administration at 60 mg/kg/day from day 20. In the control and rebamipide groups, gastric ulcer indices were reduced on day 100 compared with day 60; however, increases were observed on day 140, indicating ulcer recurrence. In the rebamipide group, the ulcer index was smaller than in the control group at each time point and the effect was significant on day 140. Although marked elevation of MPO activities was observed in the control group during the experiment, no significant elevations were seen in the rebamipide group on days 100 and 140. TBARS levels were significantly elevated in the control group on day 140, but not in the rebamipide group. Rebamipide suppressed the decrease in GSHpx activity on day 60. These results suggest that lipid peroxidation of gastric tissue mediated by free radicals from neutrophils is responsible for the recurrence of acetic acid-induced gastric ulcers in rats, and that the elimination of free radicals by rebamipide may contribute to the reduction of severity in ulcer recurrence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16184427     DOI: 10.1007/s10620-005-2812-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.

Authors:  David Y Graham; Naurang M Agrawal; Donald R Campbell; Marian M Haber; Cyndy Collis; Nancy L Lukasik; Bidan Huang
Journal:  Arch Intern Med       Date:  2002-01-28

2.  Pathological changes in the formation of Helicobacter pylori-induced gastric lesions in Mongolian gerbils.

Authors:  S Takahashi; Y Keto; H Fujita; H Muramatsu; T Nishino; S Okabe
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

3.  A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing.

Authors:  K Takagi; S Okabe; R Saziki
Journal:  Jpn J Pharmacol       Date:  1969-09

4.  Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.

Authors:  C Nagano; A Azuma; H Ishiyama; K Sekiguchi; K Imagawa; M Kikuchi
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

5.  Role of neutrophils in a rat model of gastric ulcer recurrence caused by interleukin-1 beta.

Authors:  T Watanabe; T Arakawa; T Fukuda; K Higuchi; K Kobayashi
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

6.  Changes in superoxide dismutase activity in the gastric mucosa of peptic ulcer patients.

Authors:  Y Naito; T Yoshikawa; T Ando; A Kishi; S Ueda; H Oyamada; M Kondo
Journal:  J Clin Gastroenterol       Date:  1992       Impact factor: 3.062

7.  Mechanism of hydroxyl radical scavenging by rebamipide: identification of mono-hydroxylated rebamipide as a major reaction product.

Authors:  Kazushi Sakurai; Hiroyuki Sasabe; Toshihisa Koga; Tetsuya Konishi
Journal:  Free Radic Res       Date:  2004-05

8.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

9.  Role of neutrophil-mediated inflammation in aspirin-induced gastric mucosal injury.

Authors:  N Yoshida; T Yoshikawa; Y Nakamura; M Arai; K Matsuyama; S Iinuma; N Yagi; Y Naito; M Miyasaka; M Kondo
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

10.  Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats.

Authors:  K Ogino; T Hobara; H Ishiyama; K Yamasaki; H Kobayashi; Y Izumi; S Oka
Journal:  Eur J Pharmacol       Date:  1992-02-25       Impact factor: 4.432

View more
  3 in total

1.  Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells.

Authors:  Dong Woo Kang; Gyesik Min; Do Yoon Park; Ki Whan Hong; Do Sik Min
Journal:  Exp Mol Med       Date:  2010-08-31       Impact factor: 8.718

2.  Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study.

Authors:  Yiqi Du; Zhaoshen Li; Xianbao Zhan; Jie Chen; Jun Gao; Yanfang Gong; Jianlin Ren; Liping He; Zhijian Zhang; Xiaozhong Guo; Jianshen Wu; Zibin Tian; Ruihua Shi; Bo Jiang; Dianchun Fang; Youming Li
Journal:  Dig Dis Sci       Date:  2008-02-21       Impact factor: 3.199

Review 3.  Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal.

Authors:  Tomoyuki Kashima; Hirotaka Itakura; Hideo Akiyama; Shoji Kishi
Journal:  Clin Ophthalmol       Date:  2014-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.